Citations 2
Use of beta blockers is associated with survival outcome of multiple myeloma patients treated with pomalidomide
Hwa, Yi L. , Lacy, Martha Q. , Kumar, Shaji , Muchtar, Eli , Dingli, David , Kapoor, Prashant , Hobbs, Miriam, Fonder, Amie , Warsame, Rahma , Kourelis, Taxiarchis , Hayman, Susanne R., Siddiqui, Mustaqeem , Muchtar, E , Fonder, Amie L, Gonsalves, Wilson , Kourelis, Taxiarchis V, Dispenzieri, Angela , Hwa, Yi L , Siddiqui, Mustaqeem A , Dingli, David , Gertz, Morie A. , Buadi, Francis K. , Leung, Nelson , Go, Ronald S. , Gonsalves, Wilson I. , Rajkumar, S. Vincent , Dispenzieri, Angela
European Journal of Haematology | December 1, 2020 | Volume: 106 | Issue: 3 | Pages: 433-436
Delineation of the timing of second-line therapy post–autologous stem cell transplant in patients with AL amyloidosis
Hwa, Yi L. , Warsame, Rahma , Gertz, Morie A. , Buadi, Francis K. , Lacy, Martha Q. , Kumar, Shaji , Dingli, David , Zeldenrust, Steve R., Hayman, Susanne R., Kapoor, Prashant , Kourelis, Taxiarchis , Russell, Stephen J. , Hobbs, Miriam, Fonder, Amie , Dispenzieri, Angela , Gertz, Morie A , Buadi, Francis K , Russell, Stephen J , Dingli, David , Zeldenrust, Steven R., Leung, Nelson , Gonsalves, Wilson I. , Go, Ronald S. , Rajkumar, S. Vincent , Dispenzieri, Angela
Blood | August 14, 2017 | Volume: 130 | Issue: 13 | Pages: 1578-1584
Key Points Organ progression at second-line therapy predicated inferior survival. Patients relapsing from >VGPR had a longer time to develop organ progression.